Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Current Protocols in Protein Science|February 11, 2014
Preparation and use of reverse protein microarraysElisa Pin, Giulia Federici, Emanuel F Petricoin
Clinical Biochemistry|December 26, 2012
The role of proteomics in prostate cancer research: biomarker discovery and validationElisa Pin, Claudia Fredolini, Emanuel F Petricoin
American Journal of Medical Genetics. Part A|January 13, 2009
Somatic mosaicism in a patient with Lynch syndromeChiara Pastrello, Mara Fornasarig, Elisa Pin, et al.
International Journal of Molecular Sciences|March 29, 2023
Autoantibodies against PIP4K2B and AKT3 Are Associated with Skin and Lung Fibrosis in Patients with Systemic SclerosisMarija Geroldinger-Simić, Shaghayegh Bayati, Emmie Pohjanen, et al.
Rheumatology (Oxford, England)|October 14, 2024
Autoantibodies towards HFE and SYT5 in anti-neutrophil cytoplasm antibody-associated vasculitis relapseShaghayegh Bayati, Jamsheela Nazeer, James Ng, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 13, 2023
Array-Based Multiplex and High-Throughput Serology AssaysJennie Olofsson, Ceke Hellström, Eni Andersson, et al.
Journal of Neurotrauma|April 16, 2021
Immunoglobulin A Autoreactivity toward Brain Enriched and Apoptosis-Regulating Proteins in Saliva of Athletes after Acute Concussion and Subconcussive ImpactsElisa Pin, Emanuel F Petricoin, Nelson Cortes, et al.
Journal of Proteome Research|October 5, 2016
Identification of a Novel Autoimmune Peptide Epitope of Prostein in Prostate CancerElisa Pin, Frauke Henjes, Mun-Gwan Hong, et al.
Critical Care (London, England)|March 13, 2021
Fluid proteomics of CSF and serum reveal important neuroinflammatory proteins in blood-brain barrier disruption and outcome prediction following severe traumatic brain injury: a prospective, observational studyCaroline Lindblad, Elisa Pin, David Just, et al.
Microbiology Spectrum|March 5, 2024
The serological immunogenicity of the third and fourth doses of COVID-19 vaccine in patients with inflammatory rheumatic diseases on different biologic or targeted DMARDs: a Swedish nationwide study (COVID-19-REUMA)Martina Frodlund, Per Nived, Katerina Chatzidionysiou, et al.
Pageof 5